Skip to main content
Download PDF
Download ePub

MiR-146a-5p, targeting ErbB4, promotes 3T3-L1 preadipocyte differentiation through the ERK1/2/PPAR-γ signaling pathway

Lipids in Health and Disease volume 21, Article number: 54 (2022) Cite this article

Abstract

Background

MicroRNAs (MiRNAs) are known to participate in preadipocyte differentiation, but the manner in which miR-146a-5p participates in this process remains unclear. This study was performed to examine the participation of miR-146a-5p in 3T3-L1 cell differentiation.

Material and Methods

miR-146a-5p expression was upregulated and down-regulated to examine effects on 3T3-L1 cell differentiation. Bioinformatics analysis was performed to predict its target genes, and the signaling pathway it regulates was identified by qRT-PCR and Western blotting. The expression of miR-146a-5p in epididymal adipose tissue from obese mice and in an obese mouse adipose cell model was examined by qRT-PCR.

Results

3T3-L1 cells differentiated into mature adipocytes successfully, as verified by increased areas of intracellular lipid droplets and elevated expression of mature adipocyte markers, and these cells had elevated miR-146a-5p expression. The intracellular lipid droplet and triglyceride contents and the expression of mature adipocyte markers were significantly increased in miR-146a-5p–overexpressing 3T3-L1 cells and markedly decreased in miR-146a-5p–inhibited 3T3-L1 cells. ErbB4 was a predicted target gene of miR-146a-5p. In miR-146a-5p–overexpressing 3T3-L1 cells, ErbB4 expression and ERK1/2 phosphorylation were decreased and the expression of PPAR-γ was increased; the opposite was observed in miR-146a-5p–inhibited 3T3-L1 cells. In addition, miR-146a-5p expression was significantly increased in the mouse epididymal adipose tissue and adipose cell model.

Conclusions

Upregulated miR-146a-5p expression was related to 3T3-L1 cell differentiation. MiR-146a-5p promoted 3T3-L1 cell differentiation by targeting ErbB4 and via the ERK1/2/PPAR-γ signaling pathway.

Introduction

Obesity, defined as BMI > 30 kg/m2 in clinical practice, is traditionally manifested as excessive body fat, which has adverse health effects [1]. It correlates strongly with the development of cardiovascular disease, type 2 diabetes, dyslipidemia, and other diseases [2]. A survey of a sample representing 77.5% of the global population revealed that obesity has become significantly more prevalent among boys and girls, increasing from < 1% in 1975 to 6–8% in 2016; it has also increased among women (from 6 to 15%) and men (from 3 to 11%) [3]. Obesity has become a serious social burden, and the risks of obesity-related diseases have increased in recent years. Thus, elucidation of its etiology is urgently needed to achieve effective clinical prevention and treatment.

The expansion of adipose tissue occurs mainly through preadipocyte differentiation (hyperplasia) and/or hypertrophy [4]. Both processes are regulated positively or negatively by many factors, including hormones, signal transduction pathways, delta-like non-canonical notch ligand 1–1 (an epidermal growth factor repeat-containing inhibitor), extracellular matrix components, and transcription factors [5]. The regulation of preadipocyte differentiation is generally considered to be a positive mechanism to prevent metabolic changes [6]. Mouse 3T3-L1 preadipocyte differentiation, used in the most common model of this process [7,8,9], is a complex physiological procedure resulting in increased fatty acid binding protein 4 (FABP-4), peroxisome proliferator-activated receptor γ (PPAR-γ), sterol regulatory element binding protein 1c (SREBP-1c), and adipogenic marker gene expression [10,11,12].

Recent research has shown that some miRNAs participate in adipocyte differentiation; miR-16-5p and Bat-miR-204 promote it, and miR-125a-5p and miR-23a inhibit it [13,14,15,16]. MiR-146a-5p was found to inhibit the differentiation of intramuscular preadipocytes via Akt/mTORC1 signaling in a porcine model [17], whereas Francisco et al. [18] observed elevated miR-146a-5p expression in differentiated human adipocytes. This miRNA is known to participate in the pathological processes of multiple metabolism-related diseases and obesity [19,20,21,22,23,24], but its role in adipocyte differentiation remains unclear.

Epidermal growth factor receptor-4 (EGFR4, also referred to as ErbB4), a type I transmembrane receptor tyrosine kinase, belongs to the Tyr protein kinase family and EGFR superfamily [25]. After binding to neuroregulatory proteins and other factors, this type of protein is activated and can induce various cellular responses, including mitosis and differentiation [26,27,28]. ErbB4 has been linked to the risks of type II diabetes and metabolic syndrome [29]. Zeng et al. [30] found that its deletion predisposed mice to metabolic syndrome, and observed reduced ErbB4 expression in differentiated 3T3-L1 cells. Many studies have shown that ErbB4 upregulates the phosphorylation of MAPK42/44 (also called ERK1/2) [31,32,33,34], a significant negative regulator of adipogenesis [35,36,37]. Bioinformatic analyses suggest that ErbB4 is a target gene of miR-146a [38].

This study was conducted to investigate the role of miR-146a-5p in adipocyte differentiation. This study found that miR-146a-5p expression increased significantly during 3T3-L1 differentiation. By upregulating and inhibiting the expression of miR-146a-5p, this study demonstrated that miR-146a-5p promotes 3T3-L1 cell differentiation. Molecular mechanism studies suggested that miR-146a-5p interacts with ErbB4 and promotes preadipocyte differentiation through the ERK1/2/PPAR-γ signaling pathway. Moreover, in vivo studies showed that upregulated miR-146a-5p expression correlated with adipogenesis in mice.

Materials and methods

Cell culture and differentiation

3T3-L1 cells (purchased from Shanghai FuHeng Biotechnology Company Limited, Shanghai, China) were cultured in Dulbecco’s modified eagle medium (DMEM; HyClone, Logan, UT, USA) with 10% newborn calf serum and 1% penicillin–streptomycin (P/S) supplementation in an incubator at 37 °C with 5% CO2. Cell differentiation was conducted using a modification of a previously reported protocol [39]. Briefly, the cells were inoculated in six-well plates at a density of 5 × 105/well. When the density reached complete confluence, the cells were subjected to contact inhibition for 2 days, and were then considered to be at day 0 of induced differentiation. The cell medium was replaced with medium 1 [89% DMEM, 10% fetal calf serum (FBS), 1% P/S, 1 μM dexamethasone, 5 μg/mL insulin, 2 μM rosiglitazone, and 0.5 mM 3-isobutyl-1-methylxanthine] and cultured for 48 h. Then, the cell medium was replaced with medium 2 (89% DMEM, 10% FBS, 1% P/S, and 5 μg/mL insulin) and cultured for 48 h, followed by replacement with complete medium (89% DMEM, 10% FBS, and 1% P/S) every 2 days during culture for 8 days.

Quantitative real-time polymerase chain reaction

RNAex Pro reagent (Accurate Biology, Changsha, China) was used to isolate total RNAs from the 3T3-L1 cells. MiRNAs were reverse transcribed to cDNAs using a commercially available kit (TIANGEN, Beijing, China), and mRNAs were reverse transcribed to cDNAs using the M-MLV kit (Accurate Biology). The relative concentration of miR-146a-5p was measured by quantitative real-time polymerase chain reaction (qRT-PCR) using a miRNA qPCR kit (TIANGEN) and normalized to U6. The expression of mature adipocyte marker genes was examined using a SYBR Green PCR kit (QIAGEN, Germany) and normalized to β-actin. The primer sequences are listed in Table 1.

Table 1 qRT-PCR primer sequences
Full size table

Oil Red O staining

3T3-L1 cells were inoculated in six-well plates at a density of 4 × 105/well. Oil Red O (ORO) staining was applied using a commercially available kit (Solarbio, Beijing, China). The ImageJ software was used to calculate the lipid droplet area, and the cell numbers in photographs of the samples were recorded. The average lipid accumulation in each cell was calculated as the overall area divided by the overall cell number. Thereafter, 300 μL 100% isopropyl alcohol was added to each well for 5 min to extract the lipids, the solution was diluted 20 times, and absorbance at 510 nm was read using a microplate reader.

Western blotting analysis

Cells cultured in the six-well plates were collected into 1.5-mL tubes. The cells were washed two times with phosphate buffer solution and lysed with 100 μL radio immunoprecipitation assay lysis buffer (containing 1 μL cocktail and 1 μL phosphatase inhibitor) with vortex vibration for 5 min; then, the tubes were placed on ice for 30 min. The solutions were centrifuged at 12,000 × g and 4 °C for 30 min to collect the supernatant (cell total proteins). Then, 5 × sodium dodecyl sulfate (SDS) containing β-mercaptoethanol was added at a 4:1 ratio and the samples were placed in a 100 °C water bath for 5 min. They were then subjected to 12% SDS polyacrylamide gel electrophoresis and transferred to polyvinylidene fluoride membranes. Then the membranes were blocked with 5% bovine serum albumin (BSA) at 25 °C for 1 h and incubated with primary antibodies at 4 °C for 10 h. Anti–β-actin (1:3000; Boster, China), anti–SREBP-1 (1:500; Absin, Shanghai, China), anti–delta-like non-canonical notch ligand 1 (DLK1; 1:1000; Sangon Biotech, China), anti-ErbB4 (1:1000; Santa Cruz Biotechnology, USA), anti–FABP-4 (1:750; Beyotime, China), anti–PPAR-γ (1:1000; Proteintech, China), anti–p-ERK1/2 (1:2000; Proteintech), and anti-ERK1/2 (1:1000; Proteintech) were used. After incubation, the membranes were washed three times with Tris–HCl buffered saline containing 0.1% Tween -20 (TBST). Then, they were incubated with secondary antibodies (1:5000) at 25 °C for 1 h. After washing three times with TBST, the expression of each gene was detected by chemiluminescence (4800 Multi; Tanon, Shanghai, China) using ECL reagent (Millipore, USA).

Identification of miR-146a-5p target genes

The prediction of potential miR-146a-5p target genes was performed using the miRDB (http://mirdb.org/), miRTarBase (http://mirtarbase.mbc.nctu.edu.tw/php/search.php), miRWalk (http://mirwalk.umm.uni-heidelberg.de/), and TargetScan (http://www.targetscan.org/vert_71/) online databases. The final intersection of genes was represented using VennDiagram. KEGG and GO enrichment analyses of the target genes were performed using the clusterProfiler program of the RStudio software, with screening for genes potentially involved in cell differentiation. ErbB4 was selected as the miR-146a-5p target gene in 3T3-L1 cells. The TargetScan database was used to predict binding sites of miR-146a-5p–ErbB4, and the regulatory role of miR-146a-5p for ErbB4 was verified by Western blotting and qRT-PCR analyses.

Experimental animals

Eight-week-old male C57BL/6 mice were housed in a specific pathogen–free animal facility. They were divided into a control group fed a normal diet and an obesity group fed a high-fat diet (HFD; n = 6 each) for 16 weeks. The mice were sacrificed after fasting for 6 h. The epididymal fat of each mouse was rinsed and its weight was recorded, followed by fixation with 4% paraformaldehyde for hematoxylin–eosin (HE) staining of tissue sections. Adipocyte size was observed under a microscope, and the adipocyte area was measured using Image J software. Total RNAs were extracted from the epididymal fat and the relative concentration of miR-146a-5p was examined by qRT-PCR. All animal experiments were conducted in compliance with the guidelines of the Medical Laboratory Animal Care Committee of Qingdao University (Qingdao, China).

Establishment of an obese mouse adipose cell model

The obese mouse adipose cell model was established as described by Yu et al. [40]. Specifically, differentiated 3T3-L1 cells were stimulated with 0.3 mM palmitic acid (model) or BSA (control). After 48 h, their morphology was observed by ORO staining, and the intracellular triglyceride (TG) content was measured using a TG assay kit (Nanjing Jianchen, China). qRT-PCR was performed to determine relative miR-146a-5p concentrations.

Statistical analysis

All quantitative data are presented as means ± standard deviations (SDs) from three independent replicates. Differences between two groups were analyzed using Student’s t test. GraphPad Prism (version 9; GraphPad Software, CA, USA) was used for data analysis. P < 0.05 was considered to be significant.

Results

MiR-146a-5p upregulation correlated positively with 3T3-L1 cell differentiation

The 3T3-L1 cells enlarged gradually during differentiation into mature adipocytes, and ORO staining revealed markedly increased intracellular lipid droplet content (Fig. 1A and B). The expression of mature adipocyte markers (PPAR-γ and FABP-4) increased gradually and that of the pre-adipocyte marker DLK1 decreased gradually at the protein and mRNA levels. SREBP-1c expression also increased at these levels during differentiation (Fig. 1C and D). Thus, the 3T3-L1 cells differentiated into mature adipocytes successfully. In addition, miR-146a-5p expression increased significantly during 3T3-L1 differentiation, indicating positive correlation of these processes (Fig. 1E and F).

Fig. 1
figure 1

Differentiation of 3T3-L1 cells and expression of miR-146a-5p during the process. A Oil Red O staining of 3T3-L1 cells at different differentiation timepoints (200 ×). B Relative lipid droplet areas in 3T3-L1 cells at different differentiation timepoints. C Relative mRNA expression of adipogenesis-related genes during 3T3-L1 cell differentiation. *P < 0.05 vs. undifferentiated 3T3-L1 cells. D Protein levels of adipogenesis-related genes during 3T3-L1 cell differentiation. E Flowchart of 3T3-L1 cell differentiation. F Relative expression of miR-146a-5p during 3T3-L1 differentiation. Data in (B), (C), and (F) are means ± SDs (n = 3)

Full size image

MiR-146a-5p promoted 3T3-L1 cell differentiation

MiR-146a-5p was overexpressed or down-regulated in 3T3-L1 cells successfully (Fig. 2A and B, Table 2), and the cells were induced for 12 days. The intracellular lipid droplet and TG contents were increased significantly in miR-146a-5p–overexpressing 3T3-L1 cells and decreased significantly in miR-146a-5p–inhibited 3T3-L1 cells (Fig. 2C, F, G). The relative areas of lipid droplets and the intracellular TG content were greater in miR-146a-5p–overexpressing 3T3-L1 cells than in miR-146a-5p–inhibited 3T3-L1 cells (Fig. 2D and E, Supplementary Fig. 1A and B). At the protein and mRNA levels, PPAR-γ, SREBP-1c, and FABP-4 expression was significantly increased in miR-146a-5p–overexpressing cells and decreased in miR-146a-5p–inhibited cells (Fig. 2H and I). These findings indicate that miR-146a-5p promoted 3T3-L1 cell differentiation.

Fig. 2
figure 2

MiR-146a-5p promoted 3T3-L1 adipocyte differentiation. A MiR-146a-5p was overexpressed successfully in 3T3-L1 cells. B The expression of miR-146a-5p in the 3T3-L1 cells was inhibited successfully. C–E Oil Red O staining (200 ×) and relative areas of lipid droplets in miR-146a-5p–overexpressing and –inhibited 3T3-L1 cells after differentiation for 12 days. F, G Intercellular TG contents in miR-146a-5p–overexpressing and –inhibited 3T3-L1 cells after differentiation for 12 days. H, I Expression and protein levels of PPAR-γ, SREBP-1c, and FABP-4 in miR-146a-5p–overexpressing and –inhibited 3T3-L1 cells. Data in (A), (B), and (D–H) are means ± SDs (n = 3). *P < 0.05, **P < 0.01. OC, overexpression control; IC, inhibition control

Full size image
Table 2 Nucleotide sequences of the miR-146a-5p mimic and inhibitor
Full size table

MiR-146a-5p targeted ErbB4 in 3T3-L1 cells

Eight genes including ErbB4 were identified as potential targets of miR-146a-5p (Fig. 3A). The ErbB4 level in 3T3-L1 cells was significantly elevated after 4 days of induction and markedly decreased after 12 days of induction, coinciding fully with the miR-146a-5p expression pattern (Fig. 3B). Predicted binding sites of miR-146a-5p and ErbB4 are shown in Fig. 3C. ErbB4 expression was significantly decreased in miR-146a-5p–overexpressing 3T3-L1 cells and markedly increased in miR-146a-5p–inhibited 3T3-L1 cells (Fig. 3D–H). These results suggest that miR-146a-5p interacts directly with ErbB4 and regulates its expression in 3T3-L1 cells.

Fig. 3
figure 3

MiR-146a-5p targeted and regulated the expression of ErbB4 in 3T3-L1 cells. A Potential target genes of miR-146a-5p, predicted using the miRDB, miRTarBase, miRWalk and TargetScan online databases. B Expression of ErbB4 during 3T3-L1 cell differentiation. C Binding sites of miR-146a-5p and ErbB4, predicted using the TargetScan database. D, E Expression of ErbB4 in miR-146a-5p–overexpressing and –inhibited 3T3-L1 cells. F–H Relative protein levels of ErbB4 in miR-146a-5p–overexpressing and –inhibited 3T3-L1 cells. Data in (B), (D), (E), (G), and (H) are means ± SDs (n = 3). *P < 0.05, **P < 0.01. OC, overexpression control; IC, inhibition control

Full size image

MiR-146a-5p promoted preadipocyte differentiation through the ERK1/2/PPAR-γ signaling pathway

The results of the GO and KEGG analyses suggest that the eight target genes were involved in the positive regulation of MAP kinase activity, and that ErbB4 interacts with the MAPK signaling pathway (Fig. 4A and B). As miR-146a-5p was found to regulate ErbB4 expression, it may promote preadipocyte differentiation through the ERK1/2/PPAR-γ signaling pathway. ErbB4 was inhibited or overexpressed in 3T3-L1 cells, followed by differentiation for 12 days. The inhibition of ErbB4 expression significantly increased the intracellular lipid droplet and TG contents, and ErbB4 overexpression markedly decreased these contents, in differentiated 3T3-L1 cells (Fig. 4C–G). In addition, the OD values of extracted lipid droplets were increased in ErbB4-inhibited 3T3-L1 cells, and decreased in ErbB4-overexpressing 3T3-L1 cells compared with the control (Supplementary Fig. 2A and B). In miR-146a-5p–overexpressing 3T3-L1 cells, ERK1/2 phosphorylation and ErbB4 expression were markedly decreased and PPAR-γ expression was significantly increased; the opposite was observed in miR-146a-5p–inhibited 3T3-L1 cells (Fig. 4H). ERK1/2 phosphorylation was decreased and PPAR-γ expression was increased in ErbB4-inhibited 3T3-L1 cells, with the opposite observed in ErbB4-overexpressing 3T3-L1 cells (Fig. 4I and K). These results indicate that miR-146a-5p promoted preadipocyte differentiation through the ERK1/2/PPAR-γ signaling pathway (Fig. 5).

Fig. 4
figure 4

MiR-146a-5p promoted adipocyte differentiation through the ErbB4/ERK1/2/PPAR-γ signaling pathway. A, B GO (Biological Process) and KEGG enrichment maps of eight predicted target genes of miR-146a-5p. C Oil Red O staining of ErbB4-inhibited and -overexpressing 3T3-L1 cells after differentiation for 12 days (200×). D, E Relative areas of lipid droplets in ErbB4-inhibited and -overexpressing 3T3-L1 cells after differentiation for 12 days. F, G Intercellular TG contents of ErbB4-inhibited and -overexpressing 3T3-L1 cells after differentiation for 12 days. H Protein levels of ErbB4/ERK1/2/PPAR-γ signaling pathway components in miR-146a-5p–overexpressing and –inhibited 3T3-L1 cells. I, J Protein levels of ErbB4/ERK1/2/PPAR-γ signaling pathway components in ErbB4-inhibited and -overexpressing 3T3-L1 cells. Data in D–G are means ± SDs (n = 3). *P < 0.05. OC, overexpression control; IC, inhibition control

Full size image
Fig. 5
figure 5

Proposed model of miR-146a-5p’s promotion of 3T3-L1 preadipocyte differentiation into mature adipocytes

Full size image

Upregulated miR-146a-5p expression correlated with adipogenesis in vivo

HE staining revealed that the volumes of adipocytes from HFD-fed mice were larger than those of adipocytes from control mice (Fig. 6A and B). The HFD-fed mice had greater body weights than the control mice, and upregulated miR-146a-5p expression was associated with the epididymal adipose tissue weight (Fig. 6C and D). In addition, PPAR-γ, SREBP-1c, and FABP-4 expression was significantly greater in epididymal adipose tissue from HFD-fed mice than in that from CD-fed mice (Supplementary Fig. 3). ErbB4 expression was significantly lesser in the adipose tissue from HFD-fed mice (Fig. 6E). ORO staining of the obese mouse adipose cell model revealed significantly increased intracellular lipid droplet and TG contents relative to the control (Fig. 6F and G). In addition, miR-146a-5p expression was significantly increased in the model relative to the control (Fig. 6H). These results indicate that upregulated miR-146a-5p expression correlated with adipogenesis in vivo.

Fig. 6
figure 6

MiR-146a-5p expression correlated with adipogenesis in vivo. A HE staining of epididymal adipose tissues (100×). B Cell size profiles in epididymal fat mass. C Body weights of HFD-fed and control mice. D Correlation of miR-146a-5p expression with epididymal adipose tissue weight. E Relative expression of ErbB4 in epididymal adipose tissue from HFD-fed and control mice. F Oil Red O staining of the obese and control adipose cell models (400×). G, H Intracellular TG contents and relative miR-146a-5p expression in the obese and control adipose cell models. Data in (C–E), (G), and (H) are means ± SDs. *P < 0.05, **P < 0.01

Full size image

Discussion

The effects of miR-146a-5p on preadipocyte differentiation, the main physiological process occurring during adipose tissue expansion, were investigated in this study. MiR-146a-5p expression increased during 3T3-L1 cell differentiation, promoting this process. This study also found that the promotion of adipocyte differentiation by miR-146a-5p likely occurs through the ERK1/2/PPAR-γ signaling pathway. In mice, miR-146a-5p upregulation correlated with adipogenesis. These findings suggest that miR-146a-5p plays an important role in preadipocyte differentiation.

MiRNAs affect adipocyte development and promote adipogenesis [41, 42]. Francisco et al. [18] investigated the miRNA expression profiles of human adipocytes during differentiation using global microarray analysis, and identified 70 miRNAs that were abnormally expressed in mature adipocytes compared with preadipocytes, indicating important crosstalk between miRNA expression and adipogenesis in vivo. MiR-214-3p has been found to regulate preadipocyte differentiation, during which key genes for lipogenesis are upregulated [43]. In this study, miR-146a-5p expression was markedly increased in differentiated 3T3-L1 cells. MiR-146a-5p overexpression promoted 3T3-L1 cell differentiation and enhanced mature adipocyte marker gene expression, whereas miR-146a-5p inhibition led to reduced cell differentiation and gene expression. These results are in accord with previous findings and indicate that miR-146a-5p promotes preadipocyte differentiation.

Many molecules and signaling pathways are known to be involved in preadipocyte differentiation. Yang et al. [44] observed marked miR-138 down-regulation during adipogenic differentiation, and reported that miR-138 negatively regulated the differentiation of human adipose tissue–derived mesenchymal stem cells (hAD-MSCs) by targeting EID-1. Chen et al. [35] reported that miR-125a-3p and miR-483-5p coordinated to promote adipogenesis through suppression of the RhoA/ROCK1/ERK1/2 signaling pathway in hAD-MSCs. In the present study, ErbB4 was determined to be the miR-146a-5p target gene, with an accompanying regulatory effect. Chen et al. [35] found that miR-125a-3p promoted adipogenesis by suppressing the phosphorylation of ERK1/2 and increasing the expression of PPAR-γ. KEGG enrichment analysis indicated that ErbB4 interacts with the ERK signaling pathway. In this study, miR-146a-5p overexpression reduced ERK1/2 phosphorylation and ErbB4 expression and increased PPAR-γ expression. Thus, miR-146a-5p appears to target ErbB4 to promote the differentiation of 3T3-L1 cells via the ERK1/2/PPAR-γ signaling pathway.

In contrast to these findings, Zhang et al. [45] found that miR-146a-5p expression first increased and then decreased during porcine intermuscular preadipocyte differentiation. A possible reason for this difference is that in-vivo preadipocyte differentiation is affected by adjacent tissues and multiple hormones. In this study, the effects of miR-146a-5p were further verified by the in vivo experiment, the results of which were in accordance with the in vitro results. GEO database analysis revealed greater expression of miR-146a-5p in human adipocytes than in preadipocytes (Supplementary Fig. 4A and B). Thus, multiple regulatory mechanisms may participate in preadipocyte differentiation in vivo.

Comparisons with other studies and what does the current work add to the existing knowledge

Two findings from the current work are new: a) that miR-146a-5p promotes 3T3-L1 cell differentiation; b) by regulating the ERK1/2/PPAR-γ signaling pathway.

Study strengths and limitations

This study has several strengths. It is the first to characterize the role of miR-146a-5p in preadipocyte differentiation, showing that miR-146a-5p upregulation correlated positively with 3T3-L1 cell differentiation and miR-146a-5p promoted 3T3-L1 cell differentiation via the ERK1/2/PPAR-γ signaling pathway. Several limitations of this study should be acknowledged. First, effects on the ERK1/2/PPAR-γ signaling pathway were not examined in epididymal adipose tissue from obese mice. Second, the interaction between miR-146a-5p and ErbB4 was not examined using a luciferase reporter gene assay. Further studies should be conducted to examine the role of miR-146a-5p in preadipocyte differentiation in vivo.

Conclusions

This study illustrated the key role of miR-146a-5p in preadipocyte differentiation, which suggests that miR-146a-5p could serve as a biomarker in early screening for obesity and a therapeutic target for obesity and related diseases. Clinicians can predict the risk of obesity development by examining miR-146a-5p expression in vivo.

Availability of data and materials

All data generated or analyzed in this study are available from the corresponding author for the reasonable request.

Abbreviations

BSA:

Bovine serum albumin

DEX:

Dexamethasone

DLK1:

Delta like non-canonical notch ligand 1

DMEM:

Dulbecco’s modified Eagle’s medium

ErbB4 (also named as EGFR4):

Epidermal growth factor receptor-4

FABP-4:

Fatty Acid Binding Protein 4

FBS:

Fetal bovine serum

hAD-MSCs:

Human adipose tissue-derived mesenchymal stem cells

HE:

Hematoxylin–eosin

HFD:

High-fat diet

IBMX:

3-Isobutyl-1-methylxanthine

MiRNAs:

Micrornas

NAFLD:

Non-alcoholic fatty liver disease

NCS:

Newborn calf serum

ORO:

Oil Red O

PA:

Palmitic acid

PPAR-γ:

Peroxisome Proliferator-Activated Receptor γ

P/S:

Penicillin–streptomycin

qRT-PCR:

Quantitative real-time polymerase chain reaction

ROS:

Rosiglitazone

SD:

Standard deviations

SDS:

Sodium dodecyl sulfate

SREBP-1c:

Sterol regulatory element binding protein 1c

TBST:

Tris–HCl buffered saline containing 0.1% Tween -20

TG:

Triglyceride

References

  1. Piché ME, Tchernof A, Després JP. Obesity phenotypes, diabetes, and cardiovascular diseases. Circ Res. 2020;126:1477–500.

    Article  PubMed  CAS  Google Scholar 

  2. Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K, Lee A, Marczak L, Mokdad AH, Moradi-Lakeh M, Naghavi M, et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377:13–27.

    Article  PubMed  Google Scholar 

  3. Jaacks LM, Vandevijvere S, Pan A, McGowan CJ, Wallace C, Imamura F, Mozaffarian D, Swinburn B, Ezzati M. The obesity transition: stages of the global epidemic. Lancet Diabetes Endocrinol. 2019;7:231–40.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Longo M, Zatterale F, Naderi J, Parrillo L, Formisano P, Raciti GA, Beguinot F, Miele C. Adipose Tissue Dysfunction as Determinant of Obesity-Associated Metabolic Complications. Int J Mol Sci. 2019;20(9):2358.

    Article  CAS  PubMed Central  Google Scholar 

  5. Gregoire FM, Smas CM, Sul HS. Understanding adipocyte differentiation. Physiol Rev. 1998;78:783–809.

    Article  CAS  PubMed  Google Scholar 

  6. Meldrum DR, Morris MA, Gambone JC. Obesity pandemic: causes, consequences, and solutions-but do we have the will? Fertil Steril. 2017;107:833–9.

    Article  PubMed  Google Scholar 

  7. Tian L, Song Z, Shao W, Du WW, Zhao LR, Zeng K, Yang BB, Jin T. Curcumin represses mouse 3T3-L1 cell adipogenic differentiation via inhibiting miR-17-5p and stimulating the Wnt signalling pathway effector Tcf7l2. Cell Death Dis. 2017;8: e2559.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Mackall JC, Student AK, Polakis SE, Lane MD. Induction of lipogenesis during differentiation in a “preadipocyte” cell line. J Biol Chem. 1976;251:6462–4.

    Article  CAS  PubMed  Google Scholar 

  9. Kajimoto K, Naraba H, Iwai N. MicroRNA and 3T3-L1 pre-adipocyte differentiation. RNA. 2006;12:1626–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Bindhu J, Das A. An edible fungi Pleurotus ostreatus inhibits adipogenesis via suppressing expression of PPAR γ and C/EBP α in 3T3-L1 cells: In vitro validation of gene knock out of RNAs in PPAR γ using CRISPR spcas9. Biomed Pharmacother. 2019;116:109030.

    Article  CAS  Google Scholar 

  11. Moseti D, Regassa A, Kim WK. Molecular Regulation of Adipogenesis and Potential Anti-Adipogenic Bioactive Molecules. Int J Mol Sci. 2016;17(1):124.

    Article  PubMed Central  CAS  Google Scholar 

  12. Cristancho AG, Lazar MA. Forming functional fat: a growing understanding of adipocyte differentiation. Nat Rev Mol Cell Biol. 2011;12:722–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Xu J, Zhang L, Shu G, Wang B. microRNA-16-5p promotes 3T3-L1 adipocyte differentiation through regulating EPT1. Biochem Biophys Res Commun. 2019;514:1251–6.

    Article  CAS  PubMed  Google Scholar 

  14. Jin Y, Wang J, Zhang M, Zhang S, Lei C, Chen H, Guo W, Lan X. Role of bta-miR-204 in the regulation of adipocyte proliferation, differentiation, and apoptosis. J Cell Physiol. 2019;234:11037–46.

    Article  CAS  PubMed  Google Scholar 

  15. Xu Y, Du J, Zhang P, Zhao X, Li Q, Jiang A, Jiang D, Tang G, Jiang Y, Wang J, et al. MicroRNA-125a-5p mediates 3T3-L1 preadipocyte proliferation and differentiation. Molecules. 2018;23(2):317.

    Article  PubMed Central  CAS  Google Scholar 

  16. Shen L, Zhang Y, Du J, Chen L, Luo J, Li X, Li M, Tang G, Zhang S, Zhu L. MicroRNA-23a regulates 3T3-L1 adipocyte differentiation. Gene. 2016;575:761–4.

    Article  CAS  PubMed  Google Scholar 

  17. Zhang Q, Cai R, Tang G, Zhang W, Pang W. MiR-146a-5p targeting SMAD4 and TRAF6 inhibits adipogenensis through TGF-β and AKT/mTORC1 signal pathways in porcine intramuscular preadipocytes. J Anim Sci Biotechnol. 2021;12:12.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  18. Ortega FJ, Moreno-Navarrete JM, Pardo G, Sabater M, Hummel M, Ferrer A, Rodriguez-Hermosa JI, Ruiz B, Ricart W, Peral B, Fernandez-Real JM. MiRNA expression profile of human subcutaneous adipose and during adipocyte differentiation. PLoS ONE. 2010;5: e9022.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  19. Luo Q, Feng Y, Xie Y, Shao Y, Wu M, Deng X, Yuan WE, Chen Y, Shi X. Nanoparticle-microRNA-146a-5p polyplexes ameliorate diabetic peripheral neuropathy by modulating inflammation and apoptosis. Nanomedicine. 2019;17:188–97.

    Article  CAS  PubMed  Google Scholar 

  20. Roshanravan N, Alamdari NM, Jafarabadi MA, Mohammadi A, Shabestari BR, Nasirzadeh N, Asghari S, Mansoori B, Akbarzadeh M, Ghavami A, et al. Effects of oral butyrate and inulin supplementation on inflammation-induced pyroptosis pathway in type 2 diabetes: A randomized, double-blind, placebo-controlled trial. Cytokine. 2020;131: 155101.

    Article  CAS  PubMed  Google Scholar 

  21. Chen X, Tan XR, Li SJ, Zhang XX. LncRNA NEAT1 promotes hepatic lipid accumulation via regulating miR-146a-5p/ROCK1 in nonalcoholic fatty liver disease. Life Sci. 2019;235: 116829.

    Article  CAS  PubMed  Google Scholar 

  22. Du J, Niu X, Wang Y, Kong L, Wang R, Zhang Y, Zhao S, Nan Y. MiR-146a-5p suppresses activation and proliferation of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis through directly targeting Wnt1 and Wnt5a. Sci Rep. 2015;5:16163.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Coffey AR, Kanke M, Smallwood TL, Albright J, Pitman W, Gharaibeh RZ, Hua K, Gertz E, Biddinger SB, Temel RE, et al. microRNA-146a-5p association with the cardiometabolic disease risk factor TMAO. Physiol Genomics. 2019;51:59–71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Zhong X, Liao Y, Chen L, Liu G, Feng Y, Zeng T, Zhang J. The MicroRNAs in the pathogenesis of metabolic memory. Endocrinology. 2015;156:3157–68.

    Article  CAS  PubMed  Google Scholar 

  25. Olayioye MA, Neve RM, Lane HA, Hynes NE. The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J. 2000;19:3159–67.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Junttila TT, Sundvall M, Määttä JA, Elenius K. Erbb4 and its isoforms: selective regulation of growth factor responses by naturally occurring receptor variants. Trends Cardiovasc Med. 2000;10:304–10.

    Article  CAS  PubMed  Google Scholar 

  27. Segers VFM, Dugaucquier L, Feyen E, Shakeri H, De Keulenaer GW. The role of ErbB4 in cancer. Cell Oncol (Dordr). 2020;43:335–52.

    Article  Google Scholar 

  28. Fuller SJ, Sivarajah K, Sugden PH. ErbB receptors, their ligands, and the consequences of their activation and inhibition in the myocardium. J Mol Cell Cardiol. 2008;44:831–54.

    Article  CAS  PubMed  Google Scholar 

  29. Ma Y, Gao M, Liu D. Preventing high fat diet-induced obesity and improving insulin sensitivity through neuregulin 4 gene transfer. Sci Rep. 2016;6:26242.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Zeng F, Wang Y, Kloepfer LA, Wang S, Harris RC. ErbB4 deletion predisposes to development of metabolic syndrome in mice. Am J Physiol Endocrinol Metab. 2018;315:E583–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Liang X, Ding Y, Lin F, Zhang Y, Zhou X, Meng Q, Lu X, Jiang G, Zhu H, Chen Y, et al. Overexpression of ERBB4 rejuvenates aged mesenchymal stem cells and enhances angiogenesis via PI3K/AKT and MAPK/ERK pathways. Faseb j. 2019;33:4559–70.

    Article  CAS  PubMed  Google Scholar 

  32. Wang F, Wang H, Liu X, Yu H, Zuo B, Song Z, Wang N, Huang W, Wang G. Pharmacological postconditioning with Neuregulin-1 mimics the cardioprotective effects of ischaemic postconditioning via ErbB4-dependent activation of reperfusion injury salvage kinase pathway. Mol Med. 2018;24:39.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  33. Xu J, Gong L, Qian Z, Song G, Liu J. ERBB4 promotes the proliferation of gastric cancer cells via the PI3K/Akt signaling pathway. Oncol Rep. 2018;39:2892–8.

    CAS  PubMed  Google Scholar 

  34. Carrasco-García E, Saceda M, Grasso S, Rocamora-Reverte L, Conde M, Gómez-Martínez A, García-Morales P, Ferragut JA, Martínez-Lacaci I. Small tyrosine kinase inhibitors interrupt EGFR signaling by interacting with erbB3 and erbB4 in glioblastoma cell lines. Exp Cell Res. 2011;317:1476–89.

    Article  PubMed  CAS  Google Scholar 

  35. Chen K, He H, Xie Y, Zhao L, Zhao S, Wan X, Yang W, Mo Z. miR-125a-3p and miR-483-5p promote adipogenesis via suppressing the RhoA/ROCK1/ERK1/2 pathway in multiple symmetric lipomatosis. Sci Rep. 2015;5:11909.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Ling HY, Wen GB, Feng SD, Tuo QH, Ou HS, Yao CH, Zhu BY, Gao ZP, Zhang L, Liao DF. MicroRNA-375 promotes 3T3-L1 adipocyte differentiation through modulation of extracellular signal-regulated kinase signalling. Clin Exp Pharmacol Physiol. 2011;38:239–46.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Li X, Monks B, Ge Q, Birnbaum MJ. Akt/PKB regulates hepatic metabolism by directly inhibiting PGC-1alpha transcription coactivator. Nature. 2007;447:1012–6.

    Article  CAS  PubMed  Google Scholar 

  38. Horie T, Ono K, Nishi H, Nagao K, Kinoshita M, Watanabe S, Kuwabara Y, Nakashima Y, Takanabe-Mori R, Nishi E, et al. Acute doxorubicin cardiotoxicity is associated with miR-146a-induced inhibition of the neuregulin-ErbB pathway. Cardiovasc Res. 2010;87:656–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Zebisch K, Voigt V, Wabitsch M, Brandsch M. Protocol for effective differentiation of 3T3-L1 cells to adipocytes. Anal Biochem. 2012;425:88–90.

    Article  CAS  PubMed  Google Scholar 

  40. Yu Y, Du H, Wei S, Feng L, Li J, Yao F, Zhang M, Hatch GM, Chen L. Adipocyte-derived exosomal MiR-27a induces insulin resistance in skeletal muscle through repression of PPARγ. Theranostics. 2018;8:2171–88.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Xie H, Lim B, Lodish HF. MicroRNAs induced during adipogenesis that accelerate fat cell development are downregulated in obesity. Diabetes. 2009;58:1050–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Chen L, Song J, Cui J, Hou J, Zheng X, Li C, Liu L. microRNAs regulate adipocyte differentiation. Cell Biol Int. 2013;37:533–46.

    Article  CAS  PubMed  Google Scholar 

  43. Xi FX, Wei CS, Xu YT, Ma L, He YL, Shi XE, Yang GS, Yu TY. MicroRNA-214–3p targeting Ctnnb1 promotes 3T3-L1 preadipocyte differentiation by interfering with the wnt/beta-catenin signaling pathway. Int J Mol Sci. 2019;20(8):1816.

    Article  CAS  PubMed Central  Google Scholar 

  44. Yang Z, Bian C, Zhou H, Huang S, Wang S, Liao L, Zhao RC. MicroRNA hsa-miR-138 inhibits adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells through adenovirus EID-1. Stem Cells Dev. 2011;20:259–67.

    Article  CAS  PubMed  Google Scholar 

  45. Zhang Q, Cai R, Tang G, Zhang W, Pang W. MiR-146a-5p targeting SMAD4 and TRAF6 inhibits adipogenensis through TGF-beta and AKT/mTORC1 signal pathways in porcine intramuscular preadipocytes. J Anim Sci Biotechnol. 2021;12:12.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Acknowledgements

Many thanks to Baokai Sun for assistance in this study.

Funding

This study was supported by a grant from the National Natural Science Foundation of China (No. 31770837) and the Medical and Health Technology Development Project of Shandong Province (No. 202111000637).

Author information

Authors and Affiliations

  1. Department of Infectious Disease, Qingdao Municipal Hospital, Qingdao University, 1 Jiaozhou Road, Qingdao, 266011, Shandong Province, China

    Yifen Wang, Jie Zhang, Mengke Wang & Yongning Xin

  2. School of Medicine and Pharmacy, Ocean University of China, Qingdao, China

    Xueru Chu

  3. Clinical Research Center, Qingdao Municipal Hospital, Qingdao University, 1 Jiaozhou Road, Qingdao, 266071, Shandong Province, China

    Shousheng Liu

Authors
  1. Yifen Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jie Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xueru Chu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mengke Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yongning Xin
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Shousheng Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

WYF, ZJ, CXR, WMK, and LSS conducted the experiments, analyzed data and drafted the article; LSS and XYN designed the study and revised the article. All authors have read and approved the manuscript.

Corresponding authors

Correspondence to Yongning Xin or Shousheng Liu.

Ethics declarations

Ethics approval and consent to participate

All animal experiments were conducted in accordance with the guidelines approved by the Medical Laboratory Animal Care Committee of Qingdao University.

Consent for publication

Not applicable.

Competing interests

The authors do not have any disclosures to report.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, Y., Zhang, J., Chu, X. et al. MiR-146a-5p, targeting ErbB4, promotes 3T3-L1 preadipocyte differentiation through the ERK1/2/PPAR-γ signaling pathway. Lipids Health Dis 21, 54 (2022). https://doi.org/10.1186/s12944-022-01662-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12944-022-01662-6

Keywords

Lipids in Health and Disease

ISSN: 1476-511X